Antigen (CD) | Primary leukemia cells (%) | JIH-5 cells (%) | |
---|---|---|---|
At presentation | At the second relapse | ||
T/NK cell markers | |||
CD2 | 0.2 | 0.5 | 16.4 |
CD3 | ND | ND | 1.1 |
CD5 | ND | ND | 1.1 |
CD7 | 0.3 | 0.6 | 0 |
CD56 | ND | ND | 1.4 |
cCD3 | ND | 0 | 0.3 |
B cell markers | |||
CD10 | 5.6 | 11.6 | 34.8 |
CD19 | 99.8 | 93.9 | 90.4 |
CD20 | 0.1 | 0.5 | 1.7 |
CD22 | ND | ND | 73.6 |
CD23 | ND | ND | 53.3 |
FMC-7 | ND | ND | 2.1 |
cCD79a | 97.6 | 93.6 | 80.8 |
Myeloid markers | |||
CD13 | 28.9 | 72.2 | 79.2 |
CD14 | 0.2 | 1.0 | 2.1 |
CD15 | 14.1 | 7.3 | 4.2 |
CD33 | 85.2 | 80.9 | 78.6 |
CD64 | ND | ND | 5.6 |
MPO | 11.9 | 59.1 | 66.8 |
Progenitor markers | |||
CD34 | 92.5 | 95.3 | 13.6 |
CD38 | ND | ND | 30 |
CD117 | 0.1 | 0.8 | 3.6 |
HLA-DR | 65.8 | 11.2 | 52.2 |
Adhesion markers | |||
CD11b | ND | ND | 0.9 |
Erythroid markers | |||
CD71 | ND | ND | 5.3 |
GPA | ND | ND | 1.3 |
Megakaryocytic markers | |||
CD41 | ND | ND | 47.2 |
CD61 | ND | ND | 1.1 |
Plasma cell markers | |||
CD138 | ND | ND | 1.8 |